IBM Highlights Key Challenges and Opportunities in Scaling AI for Finance SpaceX Scrubs Starship Test Flight Plans Friday Attempt as V3 Debut Approaches Geopolitical Tensions Rise as Russia Warns of Strikes on Kyiv Urges US Citizens to Leave Automatic Data Processing ADP Receives Equal Weight Rating from Analyst with 214 Price Target Morrisons to Close 100 Stores Amid Rising Cost Pressures Aluminum Prices Surge Amid Iran War Tensions Pressuring Major US Companies RadNet Inc RDNT Q1 2026 Earnings WiderThanExpected Loss Weighs on Shares IPHA Q1 2026 Earnings EPS Misses Estimates Significantly Yet Stock Rises Root Inc ROOT Q1 2026 Earnings EPS Surges Past Estimates by 1436 Shares Dip Slightly Leggett Platt Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Hecla Mining Q1 2026 Earnings EPS Falls Short of Expectations Amid Cost Pressures MBIN Q1 2026 Earnings EPS Beats Estimates by 5 Amid Mixed Market Reaction Origin Investment Corp I Warrant ORIQW Holds Steady at 016 Amid Tight Trading Range Elicio Therapeutics ELTX Bounces 45 as Biotech Sentiment Improves Pinnacle Financial Partners PNFP Holds Steady Near 97 as Trading Volume Remains Moderate Newton Golf NWTG Edges Lower 111 as Stock Tests Support at 085 Adagene ADAG Slips 106 as Stock Tests Key Support Near 356 Dropbox Founder Drew Houston Steps Down as CEO After 19Year Tenure Shifts to Executive Chairman Contango ORE Inc CTGO Q1 2026 Earnings Significant EPS Miss Weighs on Shares OYSE Hovers Near Trust Value as Slight Dip Reflects Cautious Trading Century Communities Q1 2026 Earnings Strong EPS Beat Amid Housing Market Headwinds LBRDP Q3 2025 Earnings Strong EPS Surprise Highlights Resilient Performance LSBK Q3 2025 Earnings Steady Profitability Amidst Stable Operations Saga Communications SGA Q1 2026 Earnings Negative EPS of 043 Reflects Persistent Industry Headwinds ARCO Q1 2026 Earnings Strong EPS Beat Overshadowed by Stock Decline BSBR Q1 2023 Earnings Significant EPS Miss Sends Stock Lower Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline